Back
Thomson Reuters Vs. Bright Minds Biosciences Industry Stock Comparison
Sell
38
TRI.TO
Thomson Reuters
Last Price:
$234.53
Seasonality Move:
3.12%
Sell
27
DRUG
Bright Minds Biosciences
Last Price:
$38.35
Seasonality Move:
-39.59%
Sell
38
Thomson Reuters (TRI.TO)
is a Sell
Is Thomson Reuters a Buy, Sell or Hold?
-
The current Thomson Reuters [TRI.TO] share price is $233.16. The Score for TRI.TO is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
TRI.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
-
The current Bright Minds Biosciences [DRUG] share price is $38.58. The Score for DRUG is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TRI.TO Stock Price Chart
What is Thomson Reuters's stock price today?
-
The Thomson Reuters share price today is $233.16The current trend is moderately bearish and TRI.TO is experiencing selling pressure, which indicates risk of future bearish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $38.58The current trend is moderately bearish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.
TRI.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.58 | Buy |
Relative Strength Index (14 RSI): | 47.01 | Sell |
Chaikin Money Flow: | -485606 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (226.55 - 238.89) | Buy |
Bollinger Bands (100): | (224.69 - 235.09) | Buy |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.17 | Buy |
Relative Strength Index (14 RSI): | 49.17 | Sell |
Chaikin Money Flow: | 25807 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.73 - 42.21) | Sell |
Bollinger Bands (100): | (-0.1 - 41.52) | Buy |
TRI.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 237.43 | Sell |
20-day SMA: | 234.59 | Sell |
50-day SMA: | 232.34 | Buy |
200-day SMA: | 226.13 | Buy |
8-day EMA: | 236.26 | Sell |
20-day EMA: | 235.22 | Sell |
50-day EMA: | 232.86 | Buy |
200-day EMA: | 223.37 | Buy |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.04 | Sell |
20-day SMA: | 39.8 | Sell |
50-day SMA: | 40.28 | Sell |
200-day SMA: | 10.93 | Buy |
8-day EMA: | 39.03 | Sell |
20-day EMA: | 39.39 | Sell |
50-day EMA: | 35 | Buy |
200-day EMA: | 16.73 | Buy |
Thomson Reuters Earnings Growth & TRI.TO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.64 per share, and an increase next year of $0.44 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Thomson Reuters Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |